Understanding how malaria invades red blood cells in certain Africans
Plasmodium vivax Erythrocyte Invasion Mechanisms and Humoral Immune Response in Duffy Negative Africans
This study is looking at how the malaria parasite can still infect people of African descent who don't have a certain protein that usually helps protect against it, and it aims to understand the genetic and immune responses involved, especially in Ethiopia where malaria is a big health issue.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Drexel University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11035207 on NIH RePORTER |
What this research studies
This research investigates how the malaria parasite Plasmodium vivax invades red blood cells in individuals of African ancestry who lack the Duffy antigen, which is traditionally thought to protect them from this type of malaria. The study will explore the genetic mechanisms of the parasite's invasion and the immune response of these individuals to the parasite's antigens. By analyzing gene expression and antibody levels, the research aims to uncover new insights into the interactions between the parasite and Duffy-negative red blood cells. The work will be conducted in Ethiopia, where malaria is a significant health concern.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals of African descent who are Duffy-negative and have experienced malaria infections.
Not a fit: Patients who are not of African ancestry or who are Duffy-positive may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment strategies for malaria in populations previously thought to be resistant.
How similar studies have performed: While there has been limited research on this specific topic, the investigation of malaria invasion mechanisms in different populations has shown promise in other contexts.
Where this research is happening
Philadelphia, United States
- Drexel University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Lo, Eugenia — Drexel University
- Study coordinator: Lo, Eugenia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.